HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Fei Yu Selected Research

ADS J1

9/2015ADS-J1 inhibits semen-derived amyloid fibril formation and blocks fibril-mediated enhancement of HIV-1 infection.
5/2014ADS-J1 inhibits HIV-1 infection and membrane fusion by targeting the highly conserved pocket in the gp41 NHR-trimer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Fei Yu Research Topics

Disease

116Neoplasms (Cancer)
03/2022 - 09/2008
79Infections
05/2022 - 10/2004
36Glaucoma
01/2022 - 07/2002
22Neoplasm Metastasis (Metastasis)
03/2022 - 03/2016
21Virus Diseases (Viral Diseases)
01/2022 - 03/2006
17Inflammation (Inflammations)
03/2022 - 10/2008
17Human Influenza (Influenza)
11/2021 - 08/2010
15COVID-19
01/2022 - 01/2020
15Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2021 - 02/2012
13Type 2 Diabetes Mellitus (MODY)
02/2022 - 11/2014
13Hepatocellular Carcinoma (Hepatoma)
01/2022 - 06/2008
12Cataract (Cataracts)
01/2022 - 12/2007
12Breast Neoplasms (Breast Cancer)
01/2022 - 01/2011
11Lung Neoplasms (Lung Cancer)
01/2022 - 10/2008
10Open-Angle Glaucoma (Glaucoma, Open Angle)
01/2022 - 02/2006
10Carcinogenesis
01/2022 - 06/2008
10Body Weight (Weight, Body)
01/2020 - 01/2008
10Acquired Immunodeficiency Syndrome (AIDS)
01/2019 - 04/2006
9Cardiovascular Diseases (Cardiovascular Disease)
01/2022 - 07/2006
9Hearing Loss (Hearing Impairment)
05/2016 - 02/2006
8Hypertension (High Blood Pressure)
01/2022 - 09/2005
8Obesity
09/2021 - 10/2008
7Deafness (Deaf Mutism)
01/2018 - 02/2006
6Diabetes Mellitus
01/2022 - 05/2007
6Stomach Neoplasms (Stomach Cancer)
01/2022 - 01/2015
6Glioma (Gliomas)
11/2021 - 06/2011
6Pancreatic Neoplasms (Pancreatic Cancer)
10/2021 - 08/2017
6Pain (Aches)
05/2021 - 03/2006
6Ischemia
11/2020 - 01/2013
6Necrosis
06/2020 - 02/2015
6HIV Infections (HIV Infection)
01/2019 - 04/2012
6Macular Degeneration (Age-Related Maculopathy)
10/2018 - 05/2008
5Insulin Resistance
02/2022 - 06/2015
5Astigmatism
01/2022 - 05/2011
5Limbal Stem Cell Deficiency
01/2022 - 04/2012
5Prostatic Neoplasms (Prostate Cancer)
01/2022 - 10/2017
5Uveitis
01/2021 - 02/2006
5Fibrosis (Cirrhosis)
01/2021 - 01/2014
5Diabetic Retinopathy (Retinopathy, Diabetic)
10/2019 - 11/2009
5Refractive Errors (Refractive Error)
02/2014 - 06/2006
5Low Back Pain (Lumbago)
03/2006 - 10/2002
4Dental Caries (Decay, Dental)
03/2022 - 05/2004
4Osteosarcoma (Osteogenic Sarcoma)
03/2022 - 06/2019
4Vitamin D Deficiency
01/2022 - 01/2019

Drug/Important Bio-Agent (IBA)

55Proteins (Proteins, Gene)FDA Link
04/2022 - 01/2006
25MicroRNAs (MicroRNA)IBA
01/2022 - 04/2014
23Antiviral Agents (Antivirals)IBA
05/2022 - 02/2010
21Biomarkers (Surrogate Marker)IBA
01/2022 - 02/2010
19Pharmaceutical PreparationsIBA
01/2022 - 01/2008
17Retinaldehyde (Retinal)IBA
01/2022 - 06/2008
17Messenger RNA (mRNA)IBA
10/2021 - 01/2006
13Peptides (Polypeptides)IBA
01/2022 - 06/2014
11Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2021 - 10/2008
10DNA (Deoxyribonucleic Acid)IBA
01/2022 - 09/2005
10Small Interfering RNA (siRNA)IBA
01/2022 - 05/2012
10VaccinesIBA
12/2021 - 01/2013
9CytokinesIBA
03/2022 - 01/2011
9AntibodiesIBA
09/2021 - 01/2008
8LipidsIBA
01/2022 - 08/2011
8Vitamin DFDA LinkGeneric
01/2022 - 03/2017
8Circular RNAIBA
01/2022 - 01/2017
8Anti-Bacterial Agents (Antibiotics)IBA
01/2022 - 10/2004
8AntioxidantsIBA
09/2021 - 02/2010
7RNA (Ribonucleic Acid)IBA
04/2022 - 01/2008
7Calcitriol Receptors (Calcitriol Receptor)IBA
02/2022 - 01/2016
7AntigensIBA
01/2022 - 06/2006
7Chloroquine (Aralen)FDA LinkGeneric
01/2022 - 02/2016
7Biological ProductsIBA
09/2021 - 01/2018
7Therapeutic UsesIBA
01/2021 - 10/2008
7Glucose (Dextrose)FDA LinkGeneric
01/2020 - 05/2012
7PolymersIBA
09/2019 - 08/2014
6Monoclonal AntibodiesIBA
01/2022 - 11/2013
6Hemagglutinins (Hemagglutinin)IBA
11/2021 - 03/2016
6Immunoglobulin G (IgG)IBA
09/2020 - 10/2008
6Immunoglobulin M (IgM)IBA
09/2020 - 11/2013
6LigandsIBA
01/2020 - 01/2014
6Amyloid (Amyloid Fibrils)IBA
07/2018 - 01/2015
6Mitochondrial DNA (mtDNA)IBA
12/2017 - 02/2006
6Fluorescein (Funduscein)FDA LinkGeneric
05/2012 - 12/2007
5ProdrugsIBA
01/2022 - 06/2015
5Antihypertensive Agents (Antihypertensives)IBA
01/2022 - 07/2006
5Glycoproteins (Glycoprotein)IBA
01/2022 - 12/2016
5Blood Glucose (Blood Sugar)IBA
12/2021 - 05/2012
5EnzymesIBA
09/2021 - 01/2008
5Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
08/2021 - 01/2006
5Long Noncoding RNAIBA
08/2021 - 01/2018
5IronIBA
05/2021 - 07/2012
5procyanidin B2IBA
09/2019 - 01/2012
5CholesterolIBA
11/2018 - 05/2012
5Folic Acid (Vitamin M)FDA LinkGeneric
09/2018 - 09/2012
5PhlorhizinIBA
09/2014 - 05/2012
4hydroxide ionIBA
01/2022 - 11/2017

Therapy/Procedure

63Therapeutics
03/2022 - 02/2006
17Drug Therapy (Chemotherapy)
03/2022 - 09/2009
17Lasers (Laser)
11/2019 - 07/2002
8Corneal Transplantation (Keratoplasty)
10/2020 - 02/2013
6Intraocular Lenses (Intraocular Lens)
01/2022 - 09/2009
5Highly Active Antiretroviral Therapy (HAART)
01/2019 - 01/2008
5Trabeculectomy (Trabeculoplasty)
01/2016 - 07/2002
5Physical Therapy Modalities (Physical Therapy Technique)
03/2006 - 10/2002